Newsletter | November 17, 2025

11.17.25 -- Long-Acting Delivery With Nanocrystals And Microneedles

SPONSOR

Eying The Drug Delivery Regulatory Landscape: The ‘Must See’ Watch List For 2026

Join Chief Editor Tom von Gunden as he engages drug delivery regulatory experts Rumi Young, John “Barr” Weiner, and Fran DeGrazio in a dynamic discussion of the current and near future regulatory landscape for drug and biologics delivery devices, systems, platforms, and combination products. Registration is free, sign up today!

FEATURED EDITORIAL

Long-Acting Delivery With Nanocrystals And Microneedles

For treatment of chronic diseases, microneedle patches hold great promise for bolstering patient adherence and therapeutic efficacy over time. In this episode of Sit and Deliver, videocast host Tom von Gunden talks with Alejandro Paredes, senior lecturer in pharmaceutical sciences at Queen’s University Belfast, about getting long-acting formulations into combination products leveraging With Alejananocrystals and microneedles as delivery platforms.  

Accelerating Antibody Delivery With Subcutaneous Autoinjection

In this episode of Sit and Deliver, Surf Bio CEO Bryan Mazlish discusses subcutaneous delivery of monoclonal antibodies (mAbs) and other biologics via autoinjectors, highlighting the benefits of polymer-enabled administration of high-dose antibody treatments outside infusion centers.

INDUSTRY INSIGHTS

Advanced Analytical Tools For Developing Advanced Therapeutics

Explore the advancing mass spectrometry, biophysical characterization, automated sample preparation, and high throughput analytics required to deliver medicines in a safe, compliant, and efficient manner.

Spray Drying To Enable New Inhaled Drug Products

The formulation and spray drying process can help manufacture a stable, highly respirable powder and deliver products that require a high drug load, a biologic, or rapid onset therapeutic.

The Paradigm Shift: From Scale-Up To Scale-Out In Genetic Medicine

The shift from "scale-up" to "scale-out" in genetic medicine enhances production speed, revolutionizing pharmaceutical manufacturing and accelerating life-saving therapies for global patient populations.

De-Risking FDA ANDA Submissions: Disposable Pen For Semaglutide

The BD Vystra™ Disposable Pen for Semaglutide is a generic drug-device combination, designed for usability and regulatory compliance, showing comparable performance to the reference device.

Innovations In Orally Disintegrating Tablets For Pediatric Drug Delivery

Delve into the evolving landscape of pediatric dosage forms, with a focus on how ODTs are emerging as a specialized and practical drug delivery system for children.

A Customizable Dosing Device For Precise Solid Oral Dosing

Combining POWDOSE® and Diffucaps® enables precise, individualized solid oral dosing — improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.

Streamline Your Fill And Finish Process Of Ready-To-Use Cartridges

An optimized nest design for pre-fillable cartridges was designed using numerical simulation and data analytics to improve efficiency in pharmaceutical production.

SOLUTIONS

Capabilities For Nanoformulation And Bioavailability

Gene Therapy, Oncolytic Viruses, Viral Vaccines CDMO Services

Developing Sterile Injectables